Clinical Trial Update: ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

View source ↗

Summary

AHEAD is a completed clinical trial evaluating outcomes in Hemophilia A patients treated with ADVATE and ADYNOVI as part of an outcome database.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ADVATE (antihemophilic factor VIII)
• ADYNOVI (recombinant antihemophilic factor VIII Fc fusion protein)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Status: COMPLETED